Collagen and Gelatin Market Analysis, Top 10 Company Profiles, Regional Revenue and Forecast to 2026
- In January 2021, Integra LifeSciences completed the acquisition of ACell. This acquisition enabled the company to provide more comprehensive complex wound management solutions.
- In September 2020, DSM partnered with PBC BioMed to develop regenerative bone adhesives for safer, more cost-effective surgical procedures.
The Key players in the collagen and gelatin market include Integra LifeSciences (US), Royal DSM (Netherlands), CollPlant Biotechnologies (Israel), Nitta Gelatin Inc. (Japan), Collagen Solutions plc (UK), Collagen Matrix, Inc. (US), Symatese (France), GELITA AG (Germany), PB Leiner (Belgium), Smith & Nephew (UK), Zimmer Biomet (US).
Integra LifeSciences offers innovative solutions, including leading regenerative technologies, specialty surgical solutions, and orthopedic solutions. Its products are used for treating burn and deep tissue wounds and repairing the dura mater, nerves, and tendons. The Orthopedics and Tissue Technologies business segment offers soft tissue repair and tissue regeneration products, collagen products, and small bone fixation & joint replacement solutions. The company’s leading position in the market is attributed to its strong global footprint through distributors and agents.
Geographical Analysis in Detailed?The collagen and gelatin market in the Asia Pacific region is expected to grow at the highest CAGR during the forecast period. Growth in the APAC market is driven by rising geriatric population in Japan and China, increasing prevalence of chronic wounds, and growth in the number of people suffering from pressure ulcers.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=95663122 Industry Segmentation: The orthopedic segment dominated the collagen and gelatin market in 2020:Based on application, segmented into orthopedic, wound care, dental, surgical, cardiovascular, and other applications. The global gelatin market is segmented into orthopedic, wound care and others. The orthopedic segment accounted for the largest share of 37.5% of the collagen market and 41.5% of the gelatin market in 2020, mainly due to the increasing use of these biomaterials in orthopedic surgeries and the high demand for scaffolds for bone substitutes.
The hospitals segment accounted for the largest share in 2020Based on end users, segmented into hospitals and surgical centers. In 2020, the hospitals segment accounted for the largest share of 80.6% of both collagen and gelatin market. The large share of this market segment is mainly because most surgical procedures worldwide are performed in hospitals due to the availability of advanced facilities and equipment and skilled surgeons.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=95663122